Evidence map›Paper›PMID 40624365›Full record

ArticleCommunications biology2025

Genomic analysis of Plasmodium vivax field isolates circulating in sub-Saharan Africa.

Isabelle Bouyssou, Lemu Golassa, Inès Vigan-Womas, Matthieu Schoenhals, Arsène Ratsimbasoa, Ali Ould Mohamed Salem Boukhary, Maria de Fátima Ferreira-da-Cruz, Sandrine Houzé, Laurence Ma, Feng Lu and 3 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Isabelle BouyssouInstitut Pasteur, Université Paris Cité, Malaria Genetic and Resistance Unit, INSERM U1201, Paris, France. isabelle.bouyssou@outlook.com.
Lemu GolassaAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Inès Vigan-WomasInstitut Pasteur de Dakar, Dakar, Senegal.
Matthieu SchoenhalsImmunology of Infectious Diseases, Institut Pasteur Madagascar, Antananarivo, Madagascar.
Arsène RatsimbasoaFaculté de Médecine, Université de Fianarantsoa, Fianarantsoa, Madagascar.
Ali Ould Mohamed Salem BoukharyUniversité de Nouakchott, Unité de recherche génomes et milieux, Nouakchott, Mauritania.ORCID http://orcid.org/0000-0001-7317-2776
Maria de Fátima Ferreira-da-CruzFundacão Oswaldo Cruz, Malaria Research Laboratory, Rio de Janeiro, Brazil.
Sandrine HouzéCentre National de Référence du Paludisme, Hôpital Bichat, Paris, France.
Laurence MaInstitut Pasteur, Université Paris Cite, Biomics Platform, Université Paris Cite, Biomics Platform, C2RT, Paris, France.
Feng LuDepartment of Pathogenic Biology and Immunology, School of Medicine, Key laboratory of Jiangsu province university for Nucleic Acid & Cell Fate Manipulation, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
Chetan ChitnisInstitut Pasteur, Université Paris Cité, Malaria Parasite Biology and Vaccines Unit, Paris, France.
Pascal CampagneInstitut Pasteur, Hub de Bio-informatiques et Biostatistique, Département Biologie Computationnelle, Université Paris Cité, USR 3756, Paris, France. pascal.campagne@pasteur.fr.ORCID http://orcid.org/0000-0001-7018-1896
Didier MénardInstitut Pasteur, Université Paris Cité, Malaria Genetic and Resistance Unit, INSERM U1201, Paris, France. dmenard@pasteur.fr.ORCID http://orcid.org/0000-0003-1357-4495

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-18-CE15-0026
6 · The paper itself

Abstract

Plasmodium vivax malaria is a major public health problem outside sub-Saharan Africa. However, an increasing number of P. vivax infections in Duffy-negative individuals has been reported across Africa in recent years, raising concerns that the parasites may have evolved alternative pathways to invade reticulocyte and overcome Duffy-negativity. Here, we investigated the global genetic structure and diversity of sub-Saharan African P. vivax populations, exploring possible molecular signatures of adaptation to Duffy-negative hosts. We analyzed 204 previously published P. vivax genome sequences from Africa, Southeast Asia, the Pacific Coral Triangle, and South America and generated whole-genome sequences of 133 P. vivax field isolates collected from 10 sub-Saharan African countries. Our analysis revealed four distinct geographic clusters, with clear contrasts between East/West Africa and the Indian Ocean populations. Despite the limited number of interpretable sequences from Duffy-negative individuals - attributable to low parasitemia - and the lack of clear evidence of selective pressure acting on invasion-related genes of the P. vivax parasite populations circulating in sub-Saharan Africa, our study offers valuable insights into the genetic diversity of P. vivax and lays the groundwork for future research exploring parasite adaptation to Duffy-negative hosts.

Indexed as

Genome, ProtozoanMalaria, VivaxPlasmodium vivaxAfrica South of the SaharaDuffy Blood-Group SystemGenetic VariationGenomicsHumansPhylogenyWhole Genome SequencingDuffy Blood-Group System

Identifiers

PMID40624365
PMCPMC12234883

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.